JNJ stock price today: Johnson & Johnson stock saw a dip even as the company projected robust 2026 sales and profit figures. Legal issues, especially concerning talc products, continue to impact investor sentiment. Despite these challenges, J&J's fourth-quarter results surpassed expectations, driven by strong drug and medical device sales. The company remains optimistic about its future portfolio.
